Inovio Pharmaceuticals, Inc. (INO)
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, including recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); and Lassa fever. Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800 for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.
$175.78M
Dr. Jacqueline E. Shea Ph.D.
317.00
Plymouth Meeting, PA
Dec 08, 1998
-1.34
$-5.07
1.30
4.45
-20,552.27%
-1.52
-0.49
1.91
297.43
4.45
-90.91%
-108.93%
Similar stocks (7)
Novavax, Inc.
NVAX
Vaxart, Inc.
VXRT
Elevation Oncology, Inc.
ELEV
Ocean Biomedical, Inc.
OCEA
Enveric Biosciences, Inc.
ENVB
Hepion Pharmaceuticals, Inc.
HEPA
CohBar, Inc.
CWBR
ETF Exposure (29)
ETFMG Treatments, Testing and Advancements ETF
GERM
0.52%
iShares Micro-Cap ETF
IWC
0.04422%
Vanguard Horizon Funds - Vanguard Strategic Equity Fund
VSEQX
0.02%
Vanguard Strategic Small-Cap Equity Fund Investor Shares
VSTCX
0.02%
Vanguard Russell 2000 Value Index Fund
VTWV
0.02%
iShares Russell 2000 Value ETF
IWN
0.01283%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
iShares Russell 2000 ETF
IWM
0.00672%
ProShares Ultra Russell2000
UWM
0.002445038109961857%
Dimensional U.S. Small Cap ETF
DFAS
0.00167494%
ProShares UltraPro Russell2000
URTY
0.001205131238314532%
ProShares Hedge Replication ETF
HDG
0.0010268314652181307%
Dimensional U.S. Core Equity 2 ETF
DFAC
7.3625e-4%
iShares Russell 3000 ETF
IWV
6.4e-4%
Dimensional U.S. Equity ETF
DFUS
3.3432e-4%
Dimensional US Core Equity Market ETF
DFAU
1.9385000000000002e-4%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (7)
Novavax, Inc.
NVAX
Vaxart, Inc.
VXRT
Elevation Oncology, Inc.
ELEV
Ocean Biomedical, Inc.
OCEA
Enveric Biosciences, Inc.
ENVB
Hepion Pharmaceuticals, Inc.
HEPA
CohBar, Inc.
CWBR
ETF Exposure (29)
ETFMG Treatments, Testing and Advancements ETF
GERM
0.52%
iShares Micro-Cap ETF
IWC
0.04422%
Vanguard Horizon Funds - Vanguard Strategic Equity Fund
VSEQX
0.02%
Vanguard Strategic Small-Cap Equity Fund Investor Shares
VSTCX
0.02%
Vanguard Russell 2000 Value Index Fund
VTWV
0.02%
iShares Russell 2000 Value ETF
IWN
0.01283%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
iShares Russell 2000 ETF
IWM
0.00672%
ProShares Ultra Russell2000
UWM
0.002445038109961857%
Dimensional U.S. Small Cap ETF
DFAS
0.00167494%
ProShares UltraPro Russell2000
URTY
0.001205131238314532%
ProShares Hedge Replication ETF
HDG
0.0010268314652181307%
Dimensional U.S. Core Equity 2 ETF
DFAC
7.3625e-4%
iShares Russell 3000 ETF
IWV
6.4e-4%
Dimensional U.S. Equity ETF
DFUS
3.3432e-4%
Dimensional US Core Equity Market ETF
DFAU
1.9385000000000002e-4%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%